Cargando…
Upregulation of SOX11 enhances tamoxifen resistance and promotes epithelial‐to‐mesenchymal transition via slug in MCF‐7 breast cancer cells
Resistance to tamoxifen remains a prominent conundrum in the therapy of hormone‐sensitive breast cancer. Also, the molecular underpinnings leading to tamoxifen resistance remain unclear. In the present study, we utilized the Gene Expression Omnibus database to identify that SOX11 might exert a pivot...
Autores principales: | Xiao, Yingsheng, Xie, Qin, Qin, Qingsong, Liang, Yuanke, Lin, Haoyu, Zeng, De |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496966/ https://www.ncbi.nlm.nih.gov/pubmed/32043610 http://dx.doi.org/10.1002/jcp.29629 |
Ejemplares similares
-
SOX11 and Epithelial-Mesenchymal Transition in Metastatic Serous Ovarian Cancer
por: Psilopatis, Iason, et al.
Publicado: (2023) -
USP5 promotes epithelial-mesenchymal transition by stabilizing SLUG in hepatocellular carcinoma
por: Meng, Jing, et al.
Publicado: (2019) -
SOX2 Promotes the Epithelial to Mesenchymal Transition of Esophageal Squamous Cells by Modulating Slug Expression through the Activation of STAT3/HIF-α Signaling
por: Gao, Hui, et al.
Publicado: (2015) -
Slug Is A Surrogate Marker of Epithelial to Mesenchymal Transition (EMT) in Head and Neck Cancer
por: Steinbichler, T. B., et al.
Publicado: (2020) -
miR-155 promotes proliferation and epithelial-mesenchymal transition of MCF-7 cells
por: Liu, Xiaoyan, et al.
Publicado: (2021)